7 employees
Kine Sciences is a biotechnology company that develops ultra-peptide medicines to treat chronic immune diseases.
2016
KINESCIENCES raised undisclosed on March 1, 2019
Investors: STIC Ventures
KINESCIENCES raised undisclosed on January 1, 2018
Investors: Hb Investment